Evidence map›Paper›PMID 28885570›Full record

ReviewNutrients2017

Litchi chinensis as a Functional Food and a Source of Antitumor Compounds: An Overview and a Description of Biochemical Pathways.

Sonia Emanuele, Marianna Lauricella, Giuseppe Calvaruso, Antonella D'Anneo, Michela Giuliano

Abstract readReview
In one paragraph

Review in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel Catabolic Pathway of Quercetin-3-Frontiers in nutrition · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Anti-Cancer Effect ofAntioxidants (Basel, Switzerland) · 2019
    Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sonia EmanueleDepartment of Experimental Biomedicine and Clinical Neurosciences, Laboratory of Biochemistry, University of Palermo, 90127 Palermo, Italy. sonia.emanuele@unipa.it.
Marianna LauricellaDepartment of Experimental Biomedicine and Clinical Neurosciences, Laboratory of Biochemistry, University of Palermo, 90127 Palermo, Italy. marianna.lauricella@unipa.it.ORCID 0000-0002-0157-3834
Giuseppe CalvarusoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, Laboratory of Biochemistry, University of Palermo, 90127 Palermo, Italy. giuseppe.calvaruso@unipa.it.
Antonella D'AnneoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, Laboratory of Biochemistry, University of Palermo, 90127 Palermo, Italy. antonella.danneo@unipa.it.ORCID 0000-0002-1785-8236
Michela GiulianoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, Laboratory of Biochemistry, University of Palermo, 90127 Palermo, Italy. michela.giuliano@unipa.it.ORCID 0000-0002-5114-6267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Litchi is a tasty fruit that is commercially grown for food consumption and nutritional benefits in various parts of the world. Due to its biological activities, the fruit is becoming increasingly known and deserves attention not only for its edible part, the pulp, but also for its peel and seed that contain beneficial substances with antioxidant, cancer preventive, antimicrobial, and anti-inflammatory functions. Although literature demonstrates the biological activity of Litchi components in reducing tumor cell viability in

Indexed as

AnimalsAntineoplastic Agents, PhytogenicFruitFunctional FoodHumansLitchiPlant ExtractsAntineoplastic Agents, PhytogenicPlant Extractsantitumor activityLitchi chinensis fruit extractsnutraceutical properties

Identifiers

PMID28885570
PMCPMC5622752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.